The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn’s Disease: A Cross-Sectional Study

Improving Relapse Prediction in Inflammatory Bowel Disease by Neutrophil-Derived S100A12

(2013) Jan Däbritz et al.   INFLAMMATORY BOWEL DISEASES

Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus

(2013) H. Tyden et al.   RHEUMATOLOGY

Role of the advanced glycation end products receptor in Crohn’s disease inflammation

(2013) Rachele Ciccocioppo   WORLD JOURNAL OF GASTROENTEROLOGY

The natural history of Crohn's disease: who holds the crystal ball?

(2012) Gert Van Assche   GUT

The functional −374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease

(2011) Jan Däbritz et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Behçet's Disease and Its Association with Disease Activity: A Pilot Study

(2011) Eun Chun Han et al.   Annals of Dermatology

Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications

(2011) Ravichandran Ramasamy et al.   Annals of the New York Academy of Sciences

The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease

(2011) James D. Lewis   GASTROENTEROLOGY

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

(2011) Simon P L Travis et al.   GUT

Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity

(2011) Y. Yilmaz et al.   Journal of Crohns & Colitis

Soluble Receptor for Advanced Glycation Endproducts Is Decreased in Patients with Juvenile Idiopathic Arthritis (ERA Category) and Inversely Correlates with Disease Activity and S100A12 Levels

(2011) A. MYLES et al.   JOURNAL OF RHEUMATOLOGY

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome

(2010) Anastassios C Manolakis et al.   BMC GASTROENTEROLOGY

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

(2010) Gert Van Assche et al.   Journal of Crohns & Colitis

Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications

(2009) Francesca Santilli et al.   CURRENT MEDICINAL CHEMISTRY

Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis

(2009) Shaival H. Davé et al.   JOURNAL OF LEUKOCYTE BIOLOGY

RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts

(2009) Ravichandran Ramasamy et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease

(2009) Velandai Srikanth et al.   NEUROBIOLOGY OF AGING

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases

(2009) H. Maillard-Lefebvre et al.   RHEUMATOLOGY

Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis

(2009) Yueh-Sheng Chen et al.   ARTHRITIS RESEARCH & THERAPY

Human S100A12: a novel key player in inflammation?

(2008) Jens Pietzsch et al.   AMINO ACIDS

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

(2008) E.F. Stange et al.   Journal of Crohns & Colitis

Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease

(2008) D Foell et al.   JOURNAL OF PATHOLOGY

Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population

(2008) Giuseppe Danilo Norata et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis

(2008) Jun-Ying Xiang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

(2007) Marc A. Sidler et al.   INFLAMMATORY BOWEL DISEASES